UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 12b-25/A

 

NOTIFICATION OF LATE FILING

Amendment No. 1

 

(Check One):  ☐ Form 10-K     ☐ Form 20-F     ☐ Form 11-K     ☒ Form 10-Q     ☐ Form N-CEN     ☐ Form N-CSR

 

For Period Ended: March 31, 2020

 

 

☐  Transition Report on Form 10-K                    

 

 

☐  Transition Report on Form 20-F                     

 

 

☐  Transition  Report on Form 11-K                    

 

 

☐  Transition Report on Form  10-Q                    

 
 

For the Transition Period Ended:                         

 

 

======================================================================

Nothing in this form shall be construed to imply that the Commission has

verified any information contained herein.

======================================================================

 

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

 

--------------------------------------------------------------------------------

 

PART I - REGISTRANT INFORMATION

 

BIOLARGO, INC.

--------------------------------------------------------------------------------

Full Name of Registrant

 

--------------------------------------------------------------------------------

Former Name if Applicable

 

14921 Chestnut St.

--------------------------------------------------------------------------------

Address of Principal Executive

Office (Street and Number)

 

Westminster, CA 92683

--------------------------------------------------------------------------------

City, State and Zip Code

 

 

EXPLANATORY NOTE

 

This Amendment No. 1 to Form 12b25 is submitted to correct a clerical error on the cover page of the Form 12b-25 filed May 14, 2020 by BioLargo, Inc., SEC file number 000-19709, whereby the box for “10-K” was checked, and the document was filed by the Issuer’s EDGAR filer as “NT 10-K” rather than “NT 10-Q”. This amendment corrects these errors.

 


PART II - RULES 12b-25(b) AND (c)

 

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

 

 

(a)   

The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense.

 

(b)   

The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-CEN or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and

 

(c)   

The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

 

 

 

PART III - NARRATIVE

 

State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed period. (Attach Extra Sheets if Needed)

 

The Registrant is unable to file its report on Form 10-Q without undue burden or expense to the Registrant primarily because of its reliance on contracted service providers during the COVID-19 crisis.

 

PART IV - OTHER INFORMATION

 

(1) Name and telephone number of person to contact to this notification

 

John R. Browning, Esq.

  

888

  

400-2863

(Name)

  

(Area Code)

  

(Telephone Number)

 

 


(2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months (or for such shorter) period that the registrant was required to file such reports) been filed? If answer is no, identify report(s).

 

☒ Yes ☐ No

 

(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?

 

☐ Yes ☒ No

 

If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

 

 


 

 

BIOLARGO, INC.

 

 

 (Name of Registrant as Specified in Charter)

 

 

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date:  May 18, 2020

By:

/s/ Dennis P. Calvert

 

 

 

Name:  Dennis P. Calvert

 

 

 

Title:  President and C.E.O.

 

 

 
BioLargo (QB) (USOTC:BLGO)
Historical Stock Chart
From Oct 2020 to Nov 2020 Click Here for more BioLargo (QB) Charts.
BioLargo (QB) (USOTC:BLGO)
Historical Stock Chart
From Nov 2019 to Nov 2020 Click Here for more BioLargo (QB) Charts.